Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Perlin

Showing results (261-270 of 284) with videos related to

Pageof 29
Sort By:
ACS Biomaterials Science & Engineering|January 15, 2021
Membrane-Disrupting Nanofibrous Peptide HydrogelsBiplab Sarkar, Zain Siddiqui, Peter K Nguyen, et al.
Journal of Extracellular Vesicles|June 14, 2021
Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVsMegan I Mitchell, Iddo Z Ben-Dov, Christina Liu, et al.
Frontiers in Microbiology|October 30, 2020
Recent Increase in the Prevalence of Fluconazole-Non-susceptible <i>Candida tropicalis</i> Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and GenotypingAmir Arastehfar, Süleyha Hilmioğlu-Polat, Farnaz Daneshnia, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2022
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant <i>Neisseria gonorrhoeae</i> and Other High-Threat PathogensSteven Park, Riccardo Russo, Landon Westfall, et al.
Microbiology Spectrum|February 14, 2024
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populationsElizabeth Titova, Veronica W Kan, Tara Lozy, et al.
Journal of Medicinal Chemistry|August 29, 2018
Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in VivoClare F Vickers, Ana P G Silva, Ajanta Chakraborty, et al.
Nature Communications|October 14, 2025
Molecular landscape of the fungal plasma membrane and implications for antifungal actionJennifer Jiang, Mikhail V Keniya, Anusha Puri, et al.
International Journal of Antimicrobial Agents|August 11, 2014
Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpointsMaria N Gamaletsou, George L Daikos, Thomas J Walsh, et al.
Nature Chemical Biology|October 25, 2016
Discovery of MRSA active antibiotics using primary sequence from the human microbiomeJohn Chu, Xavier Vila-Farres, Daigo Inoyama, et al.
The Journal of Infectious Diseases|May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosaKrisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Pageof 29

Showing results (261-270 of 284) with videos related to

Sort By:
Pageof 29
ACS Biomaterials Science & Engineering|January 15, 2021
Membrane-Disrupting Nanofibrous Peptide HydrogelsBiplab Sarkar, Zain Siddiqui, Peter K Nguyen, et al.
Journal of Extracellular Vesicles|June 14, 2021
Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVsMegan I Mitchell, Iddo Z Ben-Dov, Christina Liu, et al.
Frontiers in Microbiology|October 30, 2020
Recent Increase in the Prevalence of Fluconazole-Non-susceptible <i>Candida tropicalis</i> Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and GenotypingAmir Arastehfar, Süleyha Hilmioğlu-Polat, Farnaz Daneshnia, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2022
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant <i>Neisseria gonorrhoeae</i> and Other High-Threat PathogensSteven Park, Riccardo Russo, Landon Westfall, et al.
Microbiology Spectrum|February 14, 2024
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populationsElizabeth Titova, Veronica W Kan, Tara Lozy, et al.
Journal of Medicinal Chemistry|August 29, 2018
Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in VivoClare F Vickers, Ana P G Silva, Ajanta Chakraborty, et al.
Nature Communications|October 14, 2025
Molecular landscape of the fungal plasma membrane and implications for antifungal actionJennifer Jiang, Mikhail V Keniya, Anusha Puri, et al.
International Journal of Antimicrobial Agents|August 11, 2014
Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpointsMaria N Gamaletsou, George L Daikos, Thomas J Walsh, et al.
Nature Chemical Biology|October 25, 2016
Discovery of MRSA active antibiotics using primary sequence from the human microbiomeJohn Chu, Xavier Vila-Farres, Daigo Inoyama, et al.
The Journal of Infectious Diseases|May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosaKrisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Pageof 29